US equities |
NVDA $237.60 ▲+1.56% SPCX $168.45 ▲+5.97% MU $1,062.06 ▼-1.19% TSLA $379.74 ▲+2.47% MSFT $524.73 ▲+1.39% SNDK $1,714.88 ▼-0.30% INTC $117.03 ▼-1.93% META $743.09 ▲+2.06%
FinancialContent

Latest News about SDZXF

Recent news which mentions SDZXF

Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug
Tickers AMGN NEWS SDZNY SDZXF
Tags General AMGN Large Cap
From Benzinga
NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
Tickers BIIB NEWS NVS SDZNY
Tags General Topics BIIB
From Benzinga
Why Is Coherus BioSciences Stock Trading Higher On Tuesday?
Tickers CHRS NEWS SDZNY SDZXF
Tags SDZXF Biotech Market News
From Benzinga
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Tickers ABBV ALVO AMGN CI
Tags Health Care SDZNY TEVA
From Benzinga
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
Tickers AMGN NEWS SDZNY SDZXF
Tags Legal Stories That Matter SDZXF
From Benzinga
Generic/Biosimilar Player Sandoz Settles US Price Fixing Case For $265M
Tickers NEWS SDZNY SDZXF
Tags SDZNY Health Care Market News
From Benzinga
Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?
Tickers CHRS NEWS SDZNY SDZXF
Tags SDZXF Market News Biotech
From Benzinga
Venue Turmoil: Pharma Companies Oppose States' Bid to Relocate Price-Fixing Cases
Tickers SDZNY SDZXF TEVA
Tags Benzinga News Briefs
From Benzinga
Howard Hughes Holdings spinning off Seaport Entertainment to shareholders
Tickers ARMK BABA COMP HHH
Tags CH:NOVN SDZXF NVS
From MarketWatch